All In Biotech

Drug Trial Radar · NCT01203345

Intravenous Immune Globulin (IVIG) to Prevent Neonatal Infection

Randomized Clinical Trial of Intravenous Immune Globulin (IVIG) to Prevent Neonatal Infection in Very-Low-Birth-Weight Infants

Last checked: Nov 20, 2026Latest source record: Mar 22, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 2,416 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

2,416

Actual

Start

Jan 1988

Primary completion

Mar 1991

Study completion Mar 1991

Sponsor

Lead sponsor
NICHD Neonatal Research NetworkResearch network
Sponsor type
Research network
First posted
Sep 16, 2010

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2 / Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Prevention
Who can join
All sexes, up to 72 hours
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

A controlled clinical trial was conducted at eight participating centers between January 1, 1988, and March 31, 1991. Patients were randomly assigned to an intravenous immune globulin group or a control group. There were two phases to the study (see below). During phase 1 the control infants received infusions of placebo. During phase 2 the control infants received no infusion therapy.

Conditions

  • Infant, Newborn
  • Infant, Low Birth Weight
  • Infant, Small for Gestational Age
  • Infant, Premature
  • Sepsis

Interventions

  • IVIGDrug

    The infants received their first dose of study drug within 24 hours of randomization.

  • PlaceboDrug

    An equal volume of 5 percent albumin solution

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence of nosocomial infectionTime frame: 120 days of life

Locations

8 sites in 1 country. Site status is shown where the registry gives one.

  • University of Alabama at Birmingham

    Birmingham, Alabama

  • George Washington University

    Washington D.C., District of Columbia

  • University of Miami

    Miami, Florida

  • Wayne State University

    Detroit, Michigan

  • Case Western Reserve University, Rainbow Babies and Children's Hospital

    Cleveland, Ohio

  • University of Tennessee

    Memphis, Tennessee

  • University of Texas Southwestern Medical Center at Dallas

    Dallas, Texas

  • University of Vermont

    Burlington, Vermont

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.